Huntington National Bank’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $18K | Buy |
627
+78
| +14% | +$2.24K | ﹤0.01% | 1610 |
|
2025
Q1 | $18.4K | Buy |
549
+54
| +11% | +$1.81K | ﹤0.01% | 1545 |
|
2024
Q4 | $25.3K | Sell |
495
-66
| -12% | -$3.38K | ﹤0.01% | 1468 |
|
2024
Q3 | $28.7K | Sell |
561
-19
| -3% | -$971 | ﹤0.01% | 1398 |
|
2024
Q2 | $26K | Sell |
580
-3
| -0.5% | -$134 | ﹤0.01% | 1378 |
|
2024
Q1 | $27.3K | Sell |
583
-266
| -31% | -$12.5K | ﹤0.01% | 1364 |
|
2023
Q4 | $30.2K | Sell |
849
-19
| -2% | -$676 | ﹤0.01% | 1286 |
|
2023
Q3 | $25.8K | Sell |
868
-325
| -27% | -$9.67K | ﹤0.01% | 1271 |
|
2023
Q2 | $21.5K | Buy |
1,193
+344
| +41% | +$6.2K | ﹤0.01% | 1338 |
|
2023
Q1 | $13.6K | Buy |
+849
| New | +$13.6K | ﹤0.01% | 1445 |
|